Filing Details
- Accession Number:
- 0001209191-22-036085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-10 18:24:26
- Reporting Period:
- 2022-06-08
- Accepted Time:
- 2022-06-10 18:24:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Aeglea Biotherapeutics Inc. | AGLE | Pharmaceutical Preparations (2834) | 464312787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791413 | Conick Michael Jr. Hanley | C/O Aeglea Biotherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX 78746 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-08 | 28,200 | $0.71 | 36,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.
Billionaire Hedge Funds
